LT5001

LT5001 · Lumosa Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LT5001, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients [Phase 1, Phase 2]

See pricing